Brief: Pacira Biosciences Reports Fourth Quarter And Full-Year 2025 Financial Results
26/02/2026 23:20
Feb 27 (Reuters) - Pacira Biosciences Inc PCRX.O: PACIRA BIOSCIENCES REPORTS FOURTH QUARTER AND FULL-YEAR 2025 FINANCIAL RESULTS PACIRA BIOSCIENCES FY ADJUSTED EBITDA USD 186.5 MILLION VS. IBES ESTIMATE USD 204 MILLION PACIRA BIOSCIENCES FY NET INCOME USD 7 MILLION PACIRA BIOSCIENCES FY ADJUSTED NET INCOME USD 122.3 MILLION VS. IBES ESTIMATE USD 139.8 MILLION PACIRA BIOSCIENCES INC - OUTLOOK 2026 TOTAL REVENUE OF $745 MILLION TO $770 MLN Source text: ID:nGNX2vzVBn Further company coverage: PCRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pacira Biosciences
See all newsBrief: Pacira Biosciences Inc - Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote "For" All Of Pacira's Director Nominees
Brief: Pacira Biosciences Urges Stockholders To Vote "For" Election Of Pacira's Nominees On Blue Proxy Card
Brief: Doma Perpetual Urges Pacira Biosciences Shareholders To Judge Sale Price Adequacy
Brief: Doma Perpetual Capital Management Calls For Removal Of Pacira CEO And Strategic Sale
Brief: Pacira Biosciences Sends Letter To Stockholders Reiterating Superior Qualifications Of Its Board Nominees